RecruitingNot Applicable

A Non-Interventional PMCF Study Evaluating Croma Revitalis for the Correction of Fine Lines

Austria70 participantsStarted 2026-01-16

Plain-language summary

This study will serve to collect and analyze additional data on the use of the device croma revitalis for treatment of fine lines on the face including LCL and PR in the routine practice and as "real-world" performance.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Exclusion criteria

✕. Energy based device treatments that target collagen remodeling and/or production of collagen (e.g. laser therapy).
✕. Absorbable sutures (threads).
✕. HA or collagen dermal fillers.
✕. Botulinum toxin treatment.
✕. Facial lipolysis, including submental fat treatments.
✕. Facial plastic surgery.
✕. Bariatric surgery.

What they're measuring

Responder status at Week 8 after initial treatment.

Timeframe: 8 weeks after initial treatment

Trial details

NCT IDNCT07492277

SponsorCroma-Pharma GmbH

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2026-07-15

Contact for this trial

Head of Clinical Operations

+43226268468 clinical.studies@croma.at

View on ClinicalTrials.gov More Lateral Canthal Lines (LCL) trials